Computed Tomography

  • Maxime RonotEmail author
  • Romain Pommier
  • Paul Calame
  • Yvonne Purcell
  • Valérie Vilgrain


Cirrhosis is a heterogeneous and dynamic condition, associated with the progressive deposition of hepatic fibrosis that leads to increased vascular resistance at the level of the hepatic sinusoids, and to portal hypertension. Cirrhosis accounts for 90% of the causes of portal hypertension (PHT) in adults. Increased portal pressure is the main factor determining the clinical course of cirrhosis. An accurate estimation of the severity of fibrosis and PHT is essential to evaluate the disease state and prognosis, and is often the first step towards the optimization of treatment. Liver biopsy and invasive measurement of hepatic venous pressure gradient (HVPG) are the gold standard techniques for the estimation of hepatic fibrosis and PHT, respectively. However, both are invasive and, as such, cannot be used repeatedly in clinical practice. As a consequence, the need for non-invasive diagnosis tests for cirrhosis and PHT is major. Computed Tomography (CT) is a fast, standardized, and cheap cross-sectional imaging technique based on 3D X-ray technology that provides an anatomical exploration of organs. In the field of hepatology it is routinely used for the exploration of patients with chronic liver disease and portal hypertension, but also for the characterization of focal liver lesions. This chapter aims to review the role of CT in the diagnosis, grading, and prognosis of hepatic fibrosis and portal hypertension.


Cirrhosis Portal hypertension Computed tomography Dual-energy CT Perfusion CT 



Computed tomography


Dual-energy computed tomography


Fractional extravascular extracellular space


Hepatocellular carcinoma


Hepatic hydrothorax


Hepatopulmonary syndrome


Hepatic venous pressure gradient


Liver surface nodularity


Magnetic resonance imaging


Perfusion tomography perfusion


Portal hypertension


Transjugular intrahepatic portosystemic shunt


  1. 1.
    Viallet A, Huet PM, Marleau D, Villeneuve JP. Assessment of portal hemodynamics. Gastroenterology. 1980;79(3):603–5.PubMedGoogle Scholar
  2. 2.
    Bosch J, Garcia-Pagan JC, Berzigotti A, Abraldes JG. Measurement of portal pressure and its role in the management of chronic liver disease. Semin Liver Dis. 2006;26(4):348–62.PubMedCrossRefGoogle Scholar
  3. 3.
    Kim MY, Jeong WK, Baik SK. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol. 2014;20(15):4300–15.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Park HS, Kim YJ, Choe WH, Ko SY, Bak SH, Il Jung S, Jeon HJ. Diagnosis of esophageal varices on liver CT: is thin-section reconstruction necessary? Hepato-Gastroenterology. 2015;62(138):333–40.PubMedGoogle Scholar
  5. 5.
    Yu NC, Margolis D, Hsu M, Raman SS, Lu DS. Detection and grading of esophageal varices on liver CT: comparison of standard and thin-section multiplanar reconstructions in diagnostic accuracy. AJR Am J Roentgenol. 2011;197:643–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Mazzeo S, Caramella D, Gennai A, Giusti P, Neri E, Melai L, Cappelli C, Bertini R, Capria A, Rossi M, Bartolozzi C. Multidetector CT and virtual endoscopy in the evaluation of the esophagus. Abdom Imaging. 2004;29(1):2–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Cansu A, Ahmetoglu A, Kul S, Yukunc G, Fidan S, Arslan M, Topbas M. Diagnostic performance of using effervescent powder for detection and grading of esophageal varices by multi-detector computed tomography. Eur J Radiol. 2014;83(3):497–502.PubMedCrossRefGoogle Scholar
  8. 8.
    Kim SH, Kim YJ, Lee JM, Choi KD, Chung YJ, Han JK, Lee JY, Lee MW, Han CJ, Choi JI, Shin KS, Choi BI. Esophageal varices in patients with cirrhosis: multidetector CT esophagography – comparison with endoscopy. Radiology. 2007;242(3):759–68.PubMedCrossRefGoogle Scholar
  9. 9.
    Torres WE, Whitmire LF, Gedgaudas-McClees K, Bernardino ME. Computed tomography of hepatic morphologic changes in cirrhosis of the liver. J Comput Assist Tomogr. 1986;10(1):47–50.PubMedCrossRefGoogle Scholar
  10. 10.
    Brancatelli G, Federle MP, Ambrosini R, Lagalla R, Carriero A, Midiri M, Vilgrain V. Cirrhosis: CT and MR imaging evaluation. Eur J Radiol. 2007;61(1):57–69.PubMedCrossRefGoogle Scholar
  11. 11.
    Lafortune M, Matricardi L, Denys A, Favret M, Déry R, Pomier-Layrargues G. Segment 4 (the quadrate lobe): a barometer of cirrhotic liver disease at US. Radiology. 1998;206(1):157–60.PubMedCrossRefGoogle Scholar
  12. 12.
    Harbin WP, Robert NJ, Ferrucci JT Jr. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology. 1980;135(2):273–83.PubMedCrossRefGoogle Scholar
  13. 13.
    Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T. Cirrhosis: modified caudate-right lobe ratio. Radiology. 2002;224:769–74.PubMedCrossRefGoogle Scholar
  14. 14.
    Ito K, Mitchell DG, Gabata T. Enlargement of hilar peri-portal space: a sign of early cirrhosis at MR imaging. J Magn Reson Imaging. 2000;11(2):136–40.PubMedCrossRefGoogle Scholar
  15. 15.
    Tan KC. Enlargement of the hilar periportal space. Radiology. 2008;248(2):699–700.PubMedCrossRefGoogle Scholar
  16. 16.
    Zhang Y, Zhang XM, Prowda JC, Zhang HL, Sant'anna Henry C, Shih G, Emond JC, Prince MR. Changes in hepatic venous morphology with cirrhosis on MRI. J Magn Reson Imaging. 2009;29(5):1085–92.PubMedCrossRefGoogle Scholar
  17. 17.
    Ito K, Mitchell DG, Kim MJ, Awaya H, Koike S, Matsunaga N. Right posterior hepatic notch sign: a simple diagnostic MR sign of cirrhosis. J Magn Reson Imaging. 2003;18:561–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Tan KC. The right posterior hepatic notch sign. Radiology. 2008;248(1):317–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Ito K, Mitchell DG, Gabata T, Hussain SM. Expanded gallbladder fossa: simple MR imaging sign of cirrhosis. Radiology. 1999;211:723–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, Samir AE, Silva AC, Taouli B, Torbenson MS, Wells ML, Yeh B, Miller FH. Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY). 2017;42(8):2037–53.CrossRefGoogle Scholar
  21. 21.
    Rustogi R, Horowitz J, Harmath C, Wang Y, Chalian H, Ganger DR, Chen ZE, Bolster BD Jr, Shah S, Miller FH. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging. 2012;35(6):1356–64.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Venkatesh SK, Yin M, Takahashi N, Glockner JF, Talwalkar JA, Ehman RL. Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography. Abdom Imaging. 2015;40(4):766–75.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Krinsky GA, Lee VS. MR imaging of cirrhotic nodules. Abdom Imaging. 2000;25:471–82.PubMedCrossRefGoogle Scholar
  24. 24.
    Ito K, Mitchell DG, Gabata T, Hann HW, Kim PN, Fujita T, Awaya H, Honjo K, Matsunaga N. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. Radiology. 1999;212(1):235–40.PubMedCrossRefGoogle Scholar
  25. 25.
    Berzigotti A, Abraldes JG, Tandon P, Erice E, Gilabert R, García-Pagan JC, Bosch J. Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis. J Hepatol. 2010;52(6):846–53.PubMedCrossRefGoogle Scholar
  26. 26.
    Smith AD, Branch CR, Zand K, Subramony C, Zhang H, Thaggard K, Hosch R, Bryan J, Vasanji A, Griswold M, Zhang X. Liver surface nodularity quantification from routine CT images as a biomarker for detection and evaluation of cirrhosis. Radiology. 2016;280(3):771–81.PubMedCrossRefGoogle Scholar
  27. 27.
    Dodd GD III, Baron RL, Oliver JH III, Federle MP. Spectrum of imaging findings of the liver in end-stage cirrhosis. Part I. Gross morphology and diffuse abnormalities. AJR. 1999;173:1031–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Ichikawa T, Nakajima H, Nanbu A, Hori M, Araki T. Effect of injection rate of contrast material on CT of hepatocellular carcinoma. AJR. 2006;186:1413–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Brancatelli G, Baron RL, Peterson MS, Marsh W. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positives interpretation. AJR. 2003;180:1007–14.PubMedCrossRefGoogle Scholar
  30. 30.
    Itai Y, Hachiya J, Makita K, Ohtomo K, Kokubo T, Yamauchi T. Transient hepatic attenuation differences on dynamic computed tomography. J Comput Assist Tomogr. 1987;11:461–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Ahn JH, Yu JS, Hwang SH, Chung JJ, Kim JH, Kim KW. Non-tumorous arterio-portal shunts in the liver: CT and MRI findings considering mechanisms and fate. Eur Radiol. 2010;20:385–94.PubMedCrossRefGoogle Scholar
  32. 32.
    Itai Y, Matsui O. Blood flow and liver imaging. Radiology. 1997;202(2):306–14.PubMedCrossRefGoogle Scholar
  33. 33.
    Nishida O, Moriyasu F, Nakamura T, Ban N, Miura K, Sakai M, Uchino H, Miyake T. Hemodynamics of splenic artery aneurysm. Gastroenterology. 1986;90(4):1042–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Kóbori L, van der Kolk MJ, de Jong KP, Peeters PM, Klompmaker IJ, Kok T, Haagsma EB, Slooff MJ. Splenic artery aneurysms in liver transplant patients. Liver Transplant Group J Hepatol. 1997;27(5):890–3.PubMedGoogle Scholar
  35. 35.
    Heestand G, Sher L, Lightfoote J, Palmer S, Mateo R, Singh G, Moser J, Selby R, Genyk Y, Jabbour N. Characteristics and management of splenic artery aneurysm in liver transplant candidates and recipients. Am Surg. 2003;69(11):933–40.PubMedGoogle Scholar
  36. 36.
    Asthana S, Toso C, McCarthy M, Shapiro AM. The management of splenic artery aneurysm in patients awaiting liver transplantation. Clin Transpl. 2010;24(5):691–4.CrossRefGoogle Scholar
  37. 37.
    Kaya M, Baran Ş, Güya C, Kaplan MA. Prevalence and predictive factors for development of splenic artery aneurysms in cirrhosis. Indian J Gastroenterol. 2016;35(3):201–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Esen K, Balci Y, Tok S, Ucbilek E, Kara E, Kaya O. The evaluation of the right inferior phrenic artery diameter in cirrhotic patients. Jpn J Radiol. 2017 Jun 24.
  39. 39.
    Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology. 1993;188(2):405–11.PubMedCrossRefGoogle Scholar
  40. 40.
    Blomley MJ, Coulden R, Dawson P, Kormano M, Donlan P, Bufkin C, Lipton MJ. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr. 1995;19(3):424–33.PubMedCrossRefGoogle Scholar
  41. 41.
    Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol. 2001;176(3):667–73.PubMedCrossRefGoogle Scholar
  42. 42.
    Ronot M, Asselah T, Paradis V, Michoux N, Dorvillius M, Baron G, Marcellin P, Van Beers BE, Vilgrain V. Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. Radiology. 2010;256(1):135–42.PubMedCrossRefGoogle Scholar
  43. 43.
    Suzuki T, Yamada A, Komatsu D, Kurozumi M, Fujinaga Y, Ueda K, Miyagawa S, Kadoya M. Evaluation of splenic perfusion and spleen size using dynamic computed tomography: usefulness in assessing degree of liver fibrosis. Hepatol Res. 2017 Apr 1.
  44. 44.
    Gibson PR, Gibson RN, Ditchfield MR, Donlan JD. Splenomegaly—an insensitive sign of portal hypertension. Aust N Z J Med. 1990;20(6):771–4.PubMedCrossRefGoogle Scholar
  45. 45.
    Bolognesi M, Merkel C, Sacerdoti D, Nava V, Gatta A. Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis. 2002;34(2):144–50.PubMedCrossRefGoogle Scholar
  46. 46.
    Yanaga K, Tzakis AG, Shimada M, Campbell WE, Marsh JW, Stieber AC, Makowka L, Todo S, Gordon RD, Iwatsuki S, et al. Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg. 1989;210(2):180–3.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Pickhardt PJ, Malecki K, OF H, Beaumont C, Kloke J, Ziemlewicz TJ, Lubner MG. Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis. Eur Radiol. 2017;27(7):3060–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Prassopoulos P, Daskalogiannaki M, Raissaki M, Hatjidakis A, Gourtsoyiannis N. Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol. 1997;7(2):246–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Bezerra AS, D'Ippolito G, Faintuch S, Szejnfeld J, Ahmed M. Determination of splenomegaly by CT: is there a place for a single measurement? AJR Am J Roentgenol. 2005;184(5):1510–3.PubMedCrossRefGoogle Scholar
  50. 50.
    Ikegami T, Shimada M, Imura S. Recent role of splenectomy in chronic hepatic disorders. Hepatol Res. 2008;38(12):1159–71.PubMedGoogle Scholar
  51. 51.
    Tarao K, Hoshino H, Motohashi I, Iimori K, Tamai S, Ito Y, Takagi S, Oikawa Y, Unayama S, Fujiwara T, et al. Changes in liver and spleen volume in alcoholic liver fibrosis of man. Hepatology. 1989;9(4):589–93.PubMedCrossRefGoogle Scholar
  52. 52.
    Ozaki K, Matsui O, Kobayashi S, Minami T, Kitao A, Gabata T. Morphometric changes in liver cirrhosis: aetiological differences correlated with progression. Br J Radiol. 2016;89(1059):20150896.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, Ha HK, Lee MG, Hwang S, Lee SG, Yu ES, Cho EY. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology. 2006;239(1):105–12.PubMedCrossRefGoogle Scholar
  54. 54.
    Howard JM, Ghent CN, Carey LS, Flanagan PR, Valberg LS. Diagnostic efficacy of hepatic computed tomography in the detection of body iron overload. Gastroenterology. 1983;84:209–15.PubMedGoogle Scholar
  55. 55.
    Queiroz-Andrade M, Blasbalg R, Ortega CD, Rodstein MA, Baroni RH, Rocha MS, Cerri GG. MR imaging findings of iron overload. Radiographics. 2009;29(6):1575–89.PubMedCrossRefGoogle Scholar
  56. 56.
    Oelckers S, Graeff W. In situ measurement of iron overload in liver tissue by dual-energy methods. Phys Med Biol. 1996;41(7):1149–65.PubMedCrossRefGoogle Scholar
  57. 57.
    Dodd GD III, Baron RL, Oliver JH III, Federle MP. End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients. Radiology. 1999;211:357–62.PubMedCrossRefGoogle Scholar
  58. 58.
    Blachar A, Federle M, Brancatelli G. Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients. Radiology. 2001;220:329–36.PubMedCrossRefGoogle Scholar
  59. 59.
    Pillai AK, Andring B, Patel A, Trimmer C, Kalva SP. Review of portosystemic collateral pathways and endovascular interventions. Clin Radiol. 2015;70(10):1047–59.PubMedCrossRefGoogle Scholar
  60. 60.
    Kim M, Mitchell DG, Ito K. Portosystemic collaterals of the upper abdomen: review of anatomy and demonstration on MR imaging. Abdom Imaging. 2000;25:462e70.Google Scholar
  61. 61.
    Ito K, Fujita T, Shimizu A, Sasaki K, Tanabe M, Matsunaga N. Imaging findings of unusual intra- and extrahepatic portosystemic collaterals. Clin Radiol. 2009;64(2):200–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Cho KC, Patel YD, Wachsberg RH, Seeff J. Varices in portal hypertension: evaluation with CT. Radiographics. 1995;15(3):609–22.PubMedCrossRefGoogle Scholar
  63. 63.
    Kang HK, Jeong YY, Choi JH, Choi S, Chung TW, Seo JJ, Kim JK, Yoon W, Park JG. Three-dimensional multi-detector row CT portal venography in the evaluation of portosystemic collateral vessels in liver cirrhosis. Radiographics. 2002;22(5):1053–61.PubMedCrossRefGoogle Scholar
  64. 64.
    Henseler KP, Pozniak MA, Lee FT Jr, Winter TC 3rd. Three-dimensional CT angiography of spontaneous portosystemic shunts. Radiographics. 2001;21:691–704.PubMedCrossRefGoogle Scholar
  65. 65.
    Perri RE, Chiorean MV, Fidler JL, Fletcher JG, Talwalkar JA, Stadheim L, Shah ND, Kamath PS. A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices. Hepatology. 2008;47(5):1587–94.PubMedCrossRefGoogle Scholar
  66. 66.
    Lotfipour AK, Douek M, Shimoga SV, Sayer JW, Han SB, Jutabha R, Lu DS. The cost of screening esophageal varices: traditional endoscopy versus computed tomography. J Comput Assist Tomogr. 2014;38(6):963–7.PubMedCrossRefGoogle Scholar
  67. 67.
    Lafortune M, Marleau D, Breton G, Viallet A, Lavoie P, Huet PM. Portal venous system measurements in portal hypertension. Radiology. 1984;151(1):27–30.PubMedCrossRefGoogle Scholar
  68. 68.
    Saad WE. Vascular anatomy and the morphologic and hemodynamic classifications of gastric varices and spontaneous portosystemic shunts relevant to the BRTO procedure. Tech Vasc Interv Radiol. 2013;16:60e100.Google Scholar
  69. 69.
    Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology. 2004;126(4):1175–89.PubMedCrossRefGoogle Scholar
  70. 70.
    Lopera JE. Gastric varices. Radiographics. 2013;33(1):100–1.PubMedCrossRefGoogle Scholar
  71. 71.
    Kiyosue H, Ibukuro K, Maruno M, Tanoue S, Hongo N, Mori H. Multidetector CT anatomy of drainage routes of gastric varices: a pictorial review. Radiographics. 2013;33(1):87–100.PubMedCrossRefGoogle Scholar
  72. 72.
    Luo X, Wang X, Zhao Y, Ma H, Ye L, Yang L, Tsauo J, Jiang M, Li X. Real-time 3D CT image guidance for transjugular intrahepatic portosystemic shunt creation using preoperative CT: a prospective feasibility study of 20 patients. AJR Am J Roentgenol. 2017;208(1):W11–6.PubMedCrossRefGoogle Scholar
  73. 73.
    Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992;16:1343–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Dell'era A, Bosch J. Review article: The relevance of portal pressure and other risk factors in acute gastro-oesophageal variceal bleeding. Aliment Pharmacol Ther. 2004;20(Suppl 3):8–15. discussion 16–7PubMedCrossRefGoogle Scholar
  75. 75.
    Kim H, Choi D, Gwak GY, Lee JH, Lee SJ, Kim SH, Lee JY, Park Y, Chang I, Lim HK. High-risk esophageal varices in patients treated with locoregional therapies for hepatocellular carcinoma: evaluation with regular follow-up liver CT. Dig Dis Sci. 2009;54(10):2247–52.PubMedCrossRefGoogle Scholar
  76. 76.
    Deng H, Qi X, Guo X. Computed tomography for the diagnosis of varices in liver cirrhosis: a systematic review and meta-analysis of observational studies. Postgrad Med. 2017;129(3):318–28.PubMedCrossRefGoogle Scholar
  77. 77.
    Calame P, Ronot M, Bouveresse S, Cervoni JP, Vilgrain V, Delabrousse E. Predictive value of CT for first esophageal variceal bleeding in patients with cirrhosis: value of para-umbilical vein patency. Eur J Radiol. 2017;87:45–52.PubMedCrossRefGoogle Scholar
  78. 78.
    Kim M, Mitchell DG, Ito K. Portosystemic collaterals of the upper abdomen: review of anatomy and demonstration on MR imaging. Abdom Imaging. 2000;25:462–70.PubMedCrossRefGoogle Scholar
  79. 79.
    Kim M, Al-Khalili R, Miller J. Vesical varices: an unusual presentation of portal hypertension. Clin Imaging. 2015;39(5):920–2.PubMedCrossRefGoogle Scholar
  80. 80.
    Gines P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, Caballería J, Rodés J, Rozman C. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7(1):122–8.PubMedCrossRefGoogle Scholar
  81. 81.
    Thoeni RF. The role of imaging in patients with ascites. AJR Am J Roentgenol. 1995;165(1):16–8.PubMedCrossRefGoogle Scholar
  82. 82.
    Iranmanesh P, Vazquez O, Terraz S, Majno P, Spahr L, Poncet A, Morel P, Mentha G, Toso C. Accurate computed tomography-based portal pressure assessment in patients with hepatocellular carcinoma. J Hepatol. 2014;60(5):969–74.PubMedCrossRefGoogle Scholar
  83. 83.
    Kihira S, Kagen AC, Vasudevan P, Jajamovich GH, Schiano TD, Andrle AF, Babb JS, Fischman A, Taouli B. Non-invasive prediction of portal pressures using CT and MRI in chronic liver disease. Abdom Radiol (NY). 2016;41(1):42–9.CrossRefGoogle Scholar
  84. 84.
    Qi X, Li Z, Huang J, Zhu Y, Liu H, Zhou F, Liu C, Xiao C, Dong J, Zhao Y, Xu M, Xing S, Xu W, Yang C. Virtual portal pressure gradient from anatomic CT angiography. Gut. 2015;64(6):1004–5.PubMedCrossRefGoogle Scholar
  85. 85.
    Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40(3):652–9.PubMedCrossRefGoogle Scholar
  86. 86.
    Ge W, Wang Y, Cao YJ, Xie M, Ding YT, Zhang M, Yu DC. Radiological score for hemorrhage in the patients with portal hypertension. Int J Clin Exp Pathol. 2015;8(9):11517–23.PubMedPubMedCentralGoogle Scholar
  87. 87.
    Kodama H, Aikata H, Takaki S, Azakami T, Katamura Y, Kawaoka T, Hiramatsu A, Waki K, Imamura M, Kawakami Y, Takahashi S, Toyota N, Ito K, Chayama K. Evaluation of portosystemic collaterals by MDCT-MPR imaging for management of hemorrhagic esophageal varices. Eur J Radiol. 2010;76(2):239–45.PubMedCrossRefGoogle Scholar
  88. 88.
    Smith AD, Zand KA, Florez E, Sirous R, Shlapak D, Souza F, Roda M, Bryan J, Vasanji A, Griswold M, Lirette ST. Liver surface nodularity score allows prediction of cirrhosis decompensation and death. Radiology. 2017;283(3):711–22.PubMedCrossRefGoogle Scholar
  89. 89.
    Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol. 2006;12(13):2115–9.PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Rajani R, Bjornsson E, Bergquist A, Danielsson A, Gustavsson A, Grip O, Melin T, Sangfelt P, Wallerstedt S, Almer S. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther. 2010;32(9):1154–62.PubMedCrossRefGoogle Scholar
  91. 91.
    Margini C, Berzigotti A. Portal vein thrombosis: the role of imaging in the clinical setting. Dig Liver Dis. 2017;49(2):113–20.PubMedCrossRefGoogle Scholar
  92. 92.
    Mori H, Hayashi K, Uetani M, Matsuoka Y, Iwao M, Maeda H. High-attenuation recent thrombus of the portal vein: CT demonstration and clinical significance. Radiology. 1987;163(2):353–6.PubMedCrossRefGoogle Scholar
  93. 93.
    Rossi S, Rosa L, Ravetta V, Cascina A, Quaretti P, Azzaretti A, Scagnelli P, Tinelli C, Dionigi P, Calliada F. Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR Am J Roentgenol. 2006;186(3):763–73.PubMedCrossRefGoogle Scholar
  94. 94.
    Li C, Hu J, Zhou D, Zhao J, Ma K, Yin X, Wang J. Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging. BMC Cancer. 2014;14:590.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Canellas R, Mehrkhani F, Patino M, Kambadakone A, Sahani D. Characterization of portal vein thrombosis (neoplastic versus bland) on CT images using software-based texture analysis and thrombus density (Hounsfield units). AJR Am J Roentgenol. 2016;207(5):W81–7.PubMedCrossRefGoogle Scholar
  96. 96.
    Ascenti G, Sofia C, Mazziotti S, Silipigni S, D’Angelo T, Pergolizzi S, Scribano E. Dual-energy CT with iodine quantification indistinguishing between bland and neoplastic portal vein thrombosis in patients with hepatocellular carcinoma. Clin Radiol. 2016;71(9):938.e1–9.CrossRefGoogle Scholar
  97. 97.
    Chang D, Levine MS, Ginsberg GG, Rubesin SE, Laufer I. Portal hypertensive gastropathy: radiographic findings in eight patients. AJR Am J Roentgenol. 2000;175(6):1609–12.PubMedCrossRefGoogle Scholar
  98. 98.
    Ishihara K, Ishida R, Saito T, Teramoto K, Hosomura Y, Shibuya H. Computed tomography features of portal hypertensive gastropathy. J Comput Assist Tomogr. 2004;28(6):832–5.PubMedCrossRefGoogle Scholar
  99. 99.
    Holzer T, Gervaz P, Spahr L, McKee T, Bucher P, Morel P. Phlegmonous colitis: another source of sepsis in cirrhotic patients? BMC Gastroenterol. 2009;9:94.PubMedPubMedCentralCrossRefGoogle Scholar
  100. 100.
    Urrunaga NH, Rockey DC. Portal hypertensive gastropathy and colopathy. Clin Liver Dis. 2014;18(2):389–406.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Le Roy B, Gelli M, Serji B, Memeo R, Vibert E. Portal biliopathy as a complication of extrahepatic portal hypertension: etiology, presentation and management. J Visc Surg. 2015;152(3):161–6.PubMedCrossRefGoogle Scholar
  102. 102.
    Condat B, Vilgrain V, Asselah T, O’Toole D, Rufat P, Zappa M, Moreau R, Valla D. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiographycoupled with MR portography imaging study. Hepatology. 2003;37(6):1302–8.PubMedCrossRefGoogle Scholar
  103. 103.
    Kim YK, Kim Y, Shim SS. Thoracic complications of liver cirrhosis: radiologic findings. Radiographics. 2009;29(3):825–37.PubMedCrossRefGoogle Scholar
  104. 104.
    Krok KL, Cárdenas A. Hepatic hydrothorax. Semin Respir Crit Care Med. 2012;33(1):3–10.PubMedCrossRefGoogle Scholar
  105. 105.
    Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med. 1999;107:262–7.PubMedCrossRefGoogle Scholar
  106. 106.
    Noli K, Solomon M, Golding F, Charron M, Ling SC. Prevalence of hepatopulmonary syndrome in children. Pediatrics. 2008;121(3):e522–7.PubMedCrossRefGoogle Scholar
  107. 107.
    Rodríguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome—a liver- induced lung vascular disorder. N Engl J Med. 2008;358(22):2378–87.PubMedCrossRefGoogle Scholar
  108. 108.
    Devaraj A, Loveridge R, Bosanac D, Stefanidis K, Bernal W, Willars C, Wendon JA, Auzinger G, Desai SR. Portopulmonary hypertension: improved detection using CT and echocardiography in combination. Eur Radiol. 2014;24(10):2385–93.PubMedCrossRefGoogle Scholar
  109. 109.
    Rodriquez-Roisin R, Krowka MJ, Herve P, Fallon MB, Committee ERSTF-PS. Highlights of the ERS Task Force on pulmonary-hepatic vascular disorders (PHD). J Hepatol. 2005;42(6):924–7.PubMedCrossRefGoogle Scholar
  110. 110.
    McDonnell PJ, Toye PA, Hutchins GM. Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir Dis. 1983;127(4):437–41.PubMedCrossRefGoogle Scholar
  111. 111.
    Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology. 1991;100(2):520–8.PubMedCrossRefGoogle Scholar
  112. 112.
    Herve P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, Duroux P. Pulmonary vascular disorders in portal hypertension. Eur Respir J. 1998;11(5):1153–66.PubMedCrossRefGoogle Scholar
  113. 113.
    Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34–41.PubMedCrossRefGoogle Scholar
  114. 114.
    Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group. Chest. 1998;113(5):1250–6.PubMedCrossRefGoogle Scholar
  115. 115.
    Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging. 1999;14(4):270–8.PubMedCrossRefGoogle Scholar
  116. 116.
    Leise MD, Poterucha JJ, Kamath PS, Kim WR. Management of hepatic encephalopathy in the hospital. Mayo Clin Proc. 2014;89(2):241–53.PubMedPubMedCentralCrossRefGoogle Scholar
  117. 117.
    Ellul MA, Gholkar SA, Cross TJ. Hepatic encephalopathy due to liver cirrhosis. BMJ. 2015;351:h4187.PubMedCrossRefGoogle Scholar
  118. 118.
    Ohnishi K, Saito M, Sato S, Nakayama T, Takashi M, Iida S, Nomura F, Koen H, Okuda K. Direction of splenic venous flow assessed by pulsed Doppler flowmetry in patients with a large splenorenal shunt. Relation to spontaneous hepatic encephalopathy. Gastroenterology. 1985;89(1):180.PubMedCrossRefGoogle Scholar
  119. 119.
    Bonekamp D, Bonekamp S, Geiger B, Kamel IR. An elevated arterial enhancement fraction is associated with clinical and imaging indices of liver fibrosis and cirrhosis. J Comput Assist Tomogr. 2012;36(6):681–9.PubMedCrossRefGoogle Scholar
  120. 120.
    Richter S, Mucke I, Menger MD, Vollmar B. Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response. Am J Physiol Gastrointest Liver Physiol. 2000;279(2):G454–G62.PubMedCrossRefGoogle Scholar
  121. 121.
    Gulberg V, Haag K, Rossle M, Gerbes AL. Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology. 2002;35(3):630–4.PubMedCrossRefGoogle Scholar
  122. 122.
    Tsushima Y, Koizumi J, Yokoyama H, Takeda A, Kusano S. Evaluation of portal pressure by splenic perfusion measurement using dynamic CT. AJR Am J Roentgenol. 1998;170(1):153–5.PubMedCrossRefGoogle Scholar
  123. 123.
    Talakić E, Schaffellner S, Kniepeiss D, Mueller H, Stauber R, Quehenberger F, Schoellnast H. CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension? Eur Radiol. 2017 Mar 20.
  124. 124.
    Fischer MA, Brehmer K, Svensson A, Aspelin P, Brismar TB. Renal versus splenic maximum slope based perfusion CT modeling in patients with portal hypertension. Eur Radiol. 2016;26(11):4030–6.PubMedCrossRefGoogle Scholar
  125. 125.
    Silva AC, Morse BG, Hara AK, Paden RG, Hongo N, Pavlicek W. Dual-energy (spectral) CT: applications in abdominal imaging. Radiographics. 2011;31(4):1031–46. discussion 1047–50PubMedCrossRefGoogle Scholar
  126. 126.
    Lamb P, Sahani DV, Fuentes-Orrego JM, Patino M, Ghosh A, Mendonça PR. Stratification of patients with liver fibrosis using dual-energy CT. IEEE Trans Med Imaging. 2015;34(3):807–15.PubMedCrossRefGoogle Scholar
  127. 127.
    Lv P, Lin X, Gao J, Chen K. Spectral CT: preliminary studies in the liver cirrhosis. Korean J Radiol. 2012;13(4):434–42.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Zhao LQ, He W, Yan B, Wang HY, Wang J. The evaluation of haemodynamics in cirrhotic patients with spectral CT. Br J Radiol. 2013;86(1028):20130228.PubMedPubMedCentralCrossRefGoogle Scholar
  129. 129.
    Villeneuve JP, Dagenais M, Huet PM, Roy A, Lapointe R, Marleau D. The hepatic microcirculation in the isolated perfused human liver. Hepatology. 1996;23(1):24–31.PubMedCrossRefGoogle Scholar
  130. 130.
    Varenika V, Fu Y, Maher JJ, Gao D, Kakar S, Cabarrus MC, Yeh BM. Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT. Radiology. 2013;266(1):151–8.PubMedPubMedCentralCrossRefGoogle Scholar
  131. 131.
    Zissen MH, Wang ZJ, Yee J, Aslam R, Monto A, Yeh BM. Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity. Am J Roentgenol. 2013;201(6):1204–10.CrossRefGoogle Scholar
  132. 132.
    Yoon JH, Lee JM, Klotz E, Jeon JH, Lee KB, Han JK, Choi BI. Estimation of hepatic extracellular volume fraction using multiphasic liver computed tomography for hepatic fibrosis grading. Investig Radiol. 2015;50(4):290–6.CrossRefGoogle Scholar
  133. 133.
    Bandula S, Punwani S, Rosenberg WM, Jalan R, Hall AR, Dhillon A, Moon JC, Taylor SA. Equilibrium contrast-enhanced CT imaging to evaluate hepatic fibrosis: initial validation by comparison with histopathologic sampling. Radiology. 2015;275(1):136–43.PubMedCrossRefGoogle Scholar
  134. 134.
    Guo SL, Su LN, Zhai YN, Chirume WM, Lei JQ, Zhang H, Yang L, Shen XP, Wen XX, Guo YM. The clinical value of hepatic extracellular volume fraction using routine multiphasic contrast-enhanced liver CT for staging liver fibrosis. Clin Radiol. 2017;72(3):242–6.PubMedCrossRefGoogle Scholar
  135. 135.
    Zhang X, Gao X, Liu BJ, Ma K, Yan W, Liling L, Yuhong H, Fujita H. Effective staging of fibrosis by the selected texture features of liver: which one is better, CT or MR imaging? Comput Med Imaging Graph. 2015;46(Pt 2):227–36.PubMedCrossRefGoogle Scholar
  136. 136.
    Daginawala N, Li B, Buch K, Yu H, Tischler B, Qureshi MM, Soto JA, Anderson S. Using texture analyses of contrast enhanced CT to assess hepatic fibrosis. Eur J Radiol. 2016;85(3):511–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Maxime Ronot
    • 1
    • 2
    • 3
    Email author
  • Romain Pommier
    • 1
    • 2
  • Paul Calame
    • 1
    • 2
  • Yvonne Purcell
    • 1
  • Valérie Vilgrain
    • 1
    • 2
    • 3
  1. 1.Department of RadiologyHôpitaux Universitaires Paris Nord Val de Seine, BeaujonClichyFrance
  2. 2.University Paris DiderotSorbonne Paris CitéParisFrance
  3. 3.INSERM U1149Centre de Recherche Biomédicale Bichat-Beaujon, CRB3ParisFrance

Personalised recommendations